Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,338,000 | 6,860,000 | 3,364,000 | 16,056,000 | 16,628,000 |
| Depreciation Amortization | 3,573,000 | 2,365,000 | 1,166,000 | 5,755,000 | 4,626,000 |
| Income taxes - deferred | -735,000 | 33,000 | 82,000 | 561,000 | 2,067,000 |
| Accounts receivable | N/A | N/A | N/A | -1,124,000 | N/A |
| Other Working Capital | -2,856,000 | -2,056,000 | -1,515,000 | -3,902,000 | -5,571,000 |
| Other Operating Activity | 458,000 | -514,000 | 36,000 | -4,758,000 | -8,931,000 |
| Operating Cash Flow | $8,778,000 | $6,688,000 | $3,133,000 | $12,588,000 | $8,819,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -241,000 | -1,083,000 | 290,000 | 9,273,000 | 11,490,000 |
| PPE Investments | -1,413,000 | -906,000 | -449,000 | -2,046,000 | -1,504,000 |
| Net Acquisitions | N/A | N/A | N/A | -10,861,000 | -10,861,000 |
| Purchase Of Investment | -284,000 | -168,000 | -22,000 | -201,000 | -134,000 |
| Sale Of Investment | 648,000 | 536,000 | 152,000 | 232,000 | 116,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -364,000 |
| Other Investing Activity | -11,311,000 | -11,461,000 | -42,000 | -342,000 | -219,000 |
| Investing Cash Flow | $-12,601,000 | $-13,082,000 | $-71,000 | $-3,945,000 | $-1,112,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 13,976,000 | 10,038,000 | 8,509,000 | 19,006,000 | 14,186,000 |
| Debt Issued | 5,222,000 | 5,194,000 | 1,241,000 | 4,942,000 | 4,942,000 |
| Debt Repayment | -2,511,000 | -2,181,000 | -2,181,000 | -6,806,000 | -5,806,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 303,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -8,865,000 | -8,865,000 |
| Dividend Paid | -6,328,000 | -4,216,000 | -2,105,000 | -8,043,000 | -6,051,000 |
| Other Financing Activity | -6,221,000 | -1,876,000 | -7,664,000 | -8,719,000 | -4,754,000 |
| Financing Cash Flow | $4,138,000 | $6,959,000 | $-2,200,000 | $-8,485,000 | $-6,045,000 |
| Exchange Rate Effect | -39,000 | -70,000 | -15,000 | -32,000 | -41,000 |
| Beginning Cash Position | 1,350,000 | 1,350,000 | 1,350,000 | 1,225,000 | 1,225,000 |
| End Cash Position | 1,627,000 | 1,845,000 | 2,196,000 | 1,350,000 | 2,846,000 |
| Net Cash Flow | $277,000 | $495,000 | $846,000 | $125,000 | $1,620,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,778,000 | 6,688,000 | 3,133,000 | 12,588,000 | 8,819,000 |
| Capital Expenditure | -1,413,000 | -906,000 | -449,000 | -2,046,000 | -1,504,000 |
| Free Cash Flow | 7,365,000 | 5,782,000 | 2,684,000 | 10,542,000 | 7,315,000 |